US 11,696,911 B2Granted

Antiviral compounds and method for treating RNA viral infection, particularly COVID-19

AssigneeSenhwa Biosciences, Inc.

InventorTai-Sen Soong

Life of this patent

Estimating the term…

Abstract

The present invention provides a compound or a method for treating an RNA viral infection in a human, particularly COVID-19. The compound is a certain tricyclic compound.

Claims6

Dependent claims

A method for treating an RNA viral infection in a human comprising administering a therapeutically effective amount of:

or a pharmaceutically acceptable salt thereof.

Dependencies are inferred from the claim text.

Facts

Application: 17/205,823Filed 18 Mar 2021 · us provisional application
Priority: 30 Mar 2020
Published: US 2021/0308110 A17 Oct 2021
Granted: 11 Jul 2023
Term ends: Not estimatedThe source records don’t support an estimate.

Classification9 codes

A61K 31/4375
Ortho- or peri-condensed with heterocyclic ring systems: the heterocyclic ring system containing a six-membered ring having nitrogen as a ring…
A61K 31/4745
Ortho- or peri-condensed with heterocyclic ring systems: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
A61K 31/437
Ortho- or peri-condensed with heterocyclic ring systems: the heterocyclic ring system containing a five-membered ring having nitrogen as a ring…
A61K 31/519
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: ortho- or peri-condensed with heterocyclic rings

Family

Application63/001,723Us provisional application · filed 30 Mar 2020
Application63/053,908Us provisional application · filed 20 Jul 2020
US 2021/0308110 A1Pre-grant publication · published 7 Oct 2021
US 11,696,911 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results